Neumora Therapeutics, Inc. (NMRA)
3.39
-0.09
(-2.59%)
USD |
NASDAQ |
Feb 20, 16:00
3.385
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Market Cap : 566.43M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ventyx Biosciences, Inc. | 996.88M |
| Protalix Biotherapeutics, Inc. | 246.09M |
| Puma Biotechnology, Inc. | 344.17M |
| Nautilus Biotechnology, Inc. | 356.18M |
| ProKidney Corp. | 295.83M |
Market Cap Related Metrics
| Price to Book Value | 4.286 |
| Price | 3.39 |
| Earnings Yield | -43.17% |